301 related articles for article (PubMed ID: 1394190)
21. Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside.
Livingston PO; Ritter G; Srivastava P; Padavan M; Calves MJ; Oettgen HF; Old LJ
Cancer Res; 1989 Dec; 49(24 Pt 1):7045-50. PubMed ID: 2582446
[TBL] [Abstract][Full Text] [Related]
22. The immune response to disialoganglioside GD3 vaccination in normal dogs: a melanoma surface antigen vaccine.
Milner RJ; Salute M; Crawford C; Abbot JR; Farese J
Vet Immunol Immunopathol; 2006 Dec; 114(3-4):273-84. PubMed ID: 17027091
[TBL] [Abstract][Full Text] [Related]
23. Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice.
Zhang S; Graeber LA; Helling F; Ragupathi G; Adluri S; Lloyd KO; Livingston PO
Cancer Res; 1996 Jul; 56(14):3315-9. PubMed ID: 8764127
[TBL] [Abstract][Full Text] [Related]
24. Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.
Slovin SF; Ragupathi G; Musselli C; Olkiewicz K; Verbel D; Kuduk SD; Schwarz JB; Sames D; Danishefsky S; Livingston PO; Scher HI
J Clin Oncol; 2003 Dec; 21(23):4292-8. PubMed ID: 14645418
[TBL] [Abstract][Full Text] [Related]
25. GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21.
Helling F; Zhang S; Shang A; Adluri S; Calves M; Koganty R; Longenecker BM; Yao TJ; Oettgen HF; Livingston PO
Cancer Res; 1995 Jul; 55(13):2783-8. PubMed ID: 7796403
[TBL] [Abstract][Full Text] [Related]
26. A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer.
Miles DW; Towlson KE; Graham R; Reddish M; Longenecker BM; Taylor-Papadimitriou J; Rubens RD
Br J Cancer; 1996 Oct; 74(8):1292-6. PubMed ID: 8883420
[TBL] [Abstract][Full Text] [Related]
27. Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21.
Ragupathi G; Livingston PO; Hood C; Gathuru J; Krown SE; Chapman PB; Wolchok JD; Williams LJ; Oldfield RC; Hwu WJ
Clin Cancer Res; 2003 Nov; 9(14):5214-20. PubMed ID: 14614001
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen.
Yang F; Zheng XJ; Huo CX; Wang Y; Zhang Y; Ye XS
ACS Chem Biol; 2011 Mar; 6(3):252-9. PubMed ID: 21121644
[TBL] [Abstract][Full Text] [Related]
29. Immune response of pregnant cows to bovine rotavirus immunization.
Saif LJ; Smith KL; Landmeier BJ; Bohl EH; Theil KW; Todhunter DA
Am J Vet Res; 1984 Jan; 45(1):49-58. PubMed ID: 6322624
[TBL] [Abstract][Full Text] [Related]
30. Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.
Ragupathi G; Deshpande PP; Coltart DM; Kim HM; Williams LJ; Danishefsky SJ; Livingston PO
Int J Cancer; 2002 May; 99(2):207-12. PubMed ID: 11979435
[TBL] [Abstract][Full Text] [Related]
31. Immunization of Rhesus monkeys with the conjugate vaccine IGN402 induces an IgG immune response against carbohydrate and protein antigens, and cancer cells.
Kircheis R; Vondru P; Zinöcker I; Häring D; Nechansky A; Loibner H; Mudde GC
Vaccine; 2006 Mar; 24(13):2349-57. PubMed ID: 16406172
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies recognising sialyl-Tn: production and application to immunochemistry.
Devine PL; Birrell GW; Quin RJ; Shield PW
Dis Markers; 1995 Aug; 12(3):175-86. PubMed ID: 8590544
[TBL] [Abstract][Full Text] [Related]
33. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
[TBL] [Abstract][Full Text] [Related]
34. Purified human anti-Tn and anti-T antibodies specifically recognize carcinoma tissues.
Zlocowski N; Grupe V; Garay YC; Nores GA; Lardone RD; Irazoqui FJ
Sci Rep; 2019 May; 9(1):8097. PubMed ID: 31147593
[TBL] [Abstract][Full Text] [Related]
35. Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene.
Del Giudice G; Fragapane E; Bugarini R; Hora M; Henriksson T; Palla E; O'hagan D; Donnelly J; Rappuoli R; Podda A
Clin Vaccine Immunol; 2006 Sep; 13(9):1010-3. PubMed ID: 16960112
[TBL] [Abstract][Full Text] [Related]
36. Specificity of human anti-carbohydrate IgG antibodies as probed with polyacrylamide-based glycoconjugates.
Smorodin EP; Kurtenkov OA; Sergeyev BL; Pazynina GV; Bovin NV
Glycoconj J; 2004; 20(2):83-9. PubMed ID: 15001840
[TBL] [Abstract][Full Text] [Related]
37. A monoclonal antibody directed to Tn antigen.
Numata Y; Nakada H; Fukui S; Kitagawa H; Ozaki K; Inoue M; Kawasaki T; Funakoshi I; Yamashina I
Biochem Biophys Res Commun; 1990 Aug; 170(3):981-5. PubMed ID: 2390097
[TBL] [Abstract][Full Text] [Related]
38. Synthetic carbohydrate vaccines: synthesis and immunogenicity of Tn antigen conjugates.
Toyokuni T; Hakomori S; Singhal AK
Bioorg Med Chem; 1994 Nov; 2(11):1119-32. PubMed ID: 7757411
[TBL] [Abstract][Full Text] [Related]
39. Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer.
Sabbatini PJ; Ragupathi G; Hood C; Aghajanian CA; Juretzka M; Iasonos A; Hensley ML; Spassova MK; Ouerfelli O; Spriggs DR; Tew WP; Konner J; Clausen H; Abu Rustum N; Dansihefsky SJ; Livingston PO
Clin Cancer Res; 2007 Jul; 13(14):4170-7. PubMed ID: 17634545
[TBL] [Abstract][Full Text] [Related]
40. Fluorine-modified sialyl-Tn-CRM197 vaccine elicits a robust immune response.
Song C; Zheng XJ; Guo H; Cao Y; Zhang F; Li Q; Ye XS; Zhou Y
Glycoconj J; 2019 Oct; 36(5):399-408. PubMed ID: 31267246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
